REQUEST A DEMO
Total
USD $0.00
Search more companies

Progress-Farmaimpeks ZAO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Progress-Farmaimpeks ZAO Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Progress-Farmaimpeks ZAO is an enterprise in Russia, with the main office in Izhevsk. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on December 05, 2002. The total number of employees is currently 103 (2022). There was a net sales revenue increase of 6.71% reported in Progress-Farmaimpeks ZAO’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 12.72%. The net profit margin of Progress-Farmaimpeks ZAO increased by 0.06% in 2023.

Headquarters
Shkolinaya, 41
Izhevsk; Udmurt Republic; Postal Code: 426054

Contact Details: Purchase the Progress-Farmaimpeks ZAO report to view the information.

Website: http://www.farmaimpex.ru

Basic Information
Total Employees:
Purchase the Progress-Farmaimpeks ZAO report to view the information.
Outstanding Shares:
Purchase the Progress-Farmaimpeks ZAO report to view the information.
Registered Capital:
Purchase the Progress-Farmaimpeks ZAO report to view the information.
Incorporation Date:
December 05, 2002
Key Executives
Purchase this report to view the information.
Management Company
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Progress-Farmaimpeks ZAO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
6.71%
Total operating revenue
6.71%
Operating profit (EBIT)
-80.67%
Net Profit (Loss) for the Period
13.78%
Total assets
-12.72%
Total equity
6.02%
Operating Profit Margin (ROS)
-1.79%
Net Profit Margin
0.06%
Return on Equity (ROE)
0.39%
Quick Ratio
-0.27%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?